Annual Report by Private Issuer (Form C-AR)

Issuer Information

Name of Issuer:

32 Biosciences, Inc.

Legal Status of Issuer:

Form:	Corporation
Jurisdiction of Incorporation/Organization:	DELAWARE
Date of Incorporation/Organization:	06-05-2023

Physical Address of Issuer:

Address 1:	3333 GREEN BAY RD
Address 2:	SUITE 210
City:	ILLINOIS
State/Country:	ILLINOIS
Mailing Zip/Postal Code:	60064
Website of Issuer:	https://32biosciences.com/

Annual Report Disclosure Requirements

Current Number of Employees:	7.00
Total Assets Most Recent Fiscal Year-end:	2091486.00
Total Assets Prior Fiscal Year-end:	1478698.00
Cash and Cash Equivalents Most Recent Fiscal Year-end:	1857311.00
Cash and Cash Equivalents Prior Fiscal Year-end:	1183699.00
Accounts Receivable Most Recent Fiscal Year-end:	0.00
Accounts Receivable Prior Fiscal Year-end:	0.00
Short-term Debt Most Recent Fiscal Year-end:	358681.00
Short-term Debt Prior Fiscal Year-end:	14917.00
Long-term Debt Most Recent Fiscal Year-end:	5378215.00
Long-term Debt Prior Fiscal Year-end:	3177281.00
Revenue/Sales Most Recent Fiscal Year-end:	0.00
Revenue/Sales Prior Fiscal Year-end:	53691.00
Cost of Goods Sold Most Recent Fiscal Year-end:	0.00
Cost of Goods Sold Prior Fiscal Year-end:	0.00
Taxes Paid Most Recent Fiscal Year-end:	0.00
Taxes Paid Prior Fiscal Year-end:	0.00
Net Income Most Recent Fiscal Year-end:	-3091429.00
Net Income Prior Fiscal Year-end:	-1742797.00

Signature

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.

Issuer:	32 Biosciences, Inc.
Signature:	Peter Farmakis
Title:	Chief Executive Officer

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:	Peter Farmakis
Title:	Chairman
Date:	04-24-2026

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:	Jayson Slotnik
Title:	Director
Date:	04-24-2026

Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.

Signature:	Franklin R. Cockerill III
Title:	Director
Date:	04-24-2026